What's new in the field of prostate cancer chemoprevention?

Kanwaljit Mahal, Javier Hernandez, Joseph W Basler, Ian M. Thompson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Original languageEnglish
Pages (from-to)237-242
Number of pages6
JournalCurrent Oncology Reports
Volume6
Issue number3
StatePublished - May 2004

Fingerprint

Chemoprevention
Prostatic Neoplasms
Neoplasms
Cyclooxygenase Inhibitors
Selenium
Vitamin E

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mahal, K., Hernandez, J., Basler, J. W., & Thompson, I. M. (2004). What's new in the field of prostate cancer chemoprevention? Current Oncology Reports, 6(3), 237-242.

What's new in the field of prostate cancer chemoprevention? / Mahal, Kanwaljit; Hernandez, Javier; Basler, Joseph W; Thompson, Ian M.

In: Current Oncology Reports, Vol. 6, No. 3, 05.2004, p. 237-242.

Research output: Contribution to journalArticle

Mahal, K, Hernandez, J, Basler, JW & Thompson, IM 2004, 'What's new in the field of prostate cancer chemoprevention?', Current Oncology Reports, vol. 6, no. 3, pp. 237-242.
Mahal K, Hernandez J, Basler JW, Thompson IM. What's new in the field of prostate cancer chemoprevention? Current Oncology Reports. 2004 May;6(3):237-242.
Mahal, Kanwaljit ; Hernandez, Javier ; Basler, Joseph W ; Thompson, Ian M. / What's new in the field of prostate cancer chemoprevention?. In: Current Oncology Reports. 2004 ; Vol. 6, No. 3. pp. 237-242.
@article{d65dbfd0af5f461daccdca851697b649,
title = "What's new in the field of prostate cancer chemoprevention?",
abstract = "Chemoprevention trials for several malignancies are completed, planned, or underway. Prostate cancer is one of the most common forms of cancer and understandably has received considerable recent attention as a potential target for chemoprevention. This article examines chemoprevention trials for prostate cancer, including the Prostate Cancer Prevention Trial, Selenium and Vitamin E Cancer Prevention Trial, and cyclooxygenase inhibitors in the prevention of prostate cancer.",
author = "Kanwaljit Mahal and Javier Hernandez and Basler, {Joseph W} and Thompson, {Ian M.}",
year = "2004",
month = "5",
language = "English",
volume = "6",
pages = "237--242",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "3",

}

TY - JOUR

T1 - What's new in the field of prostate cancer chemoprevention?

AU - Mahal, Kanwaljit

AU - Hernandez, Javier

AU - Basler, Joseph W

AU - Thompson, Ian M.

PY - 2004/5

Y1 - 2004/5

N2 - Chemoprevention trials for several malignancies are completed, planned, or underway. Prostate cancer is one of the most common forms of cancer and understandably has received considerable recent attention as a potential target for chemoprevention. This article examines chemoprevention trials for prostate cancer, including the Prostate Cancer Prevention Trial, Selenium and Vitamin E Cancer Prevention Trial, and cyclooxygenase inhibitors in the prevention of prostate cancer.

AB - Chemoprevention trials for several malignancies are completed, planned, or underway. Prostate cancer is one of the most common forms of cancer and understandably has received considerable recent attention as a potential target for chemoprevention. This article examines chemoprevention trials for prostate cancer, including the Prostate Cancer Prevention Trial, Selenium and Vitamin E Cancer Prevention Trial, and cyclooxygenase inhibitors in the prevention of prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=5444227917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5444227917&partnerID=8YFLogxK

M3 - Article

C2 - 15066236

AN - SCOPUS:5444227917

VL - 6

SP - 237

EP - 242

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 3

ER -